Guidelines represent a major shift in CVD risk management

New guidelines on preventing cardiovascular disease mean a substantial change in the assessment and management of risk, including a shift away from aiming toward specific LDL targets. The change is a big one for doctors, who have for years worked with patients to manage cholesterol numbers. "If you ask patients, 'Why do you take a statin?' they say 'to lower my cholesterol level,' not 'to lower my cardiovascular risk,'" said internist Dr. Steven Woloshin. But cardiologist Dr. Valentin Fuster points out that in addition to influencing cholesterol levels, statins reduce clotting and inflammation, while drugs whose sole effect is lower LDL levels do not appear to be effective in other areas.

View Full Article in:

New York Times (tiered subscription model), The · New York Times (tiered subscription model), The · Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY